CDK4 and interstitial lung disease: Mechanistically, the elevated levels of inflammatory cell could be a consequence of the palbociclib-induced cell cycle arrest with relevant cellular senescence, a phenomenon called “senescence associated secretory phenotype.” This supports the biological basis of ILD with CDK4/6 inhibitors and relevant inflammatory-mediated mechanism, which is also compatible with the observed early latency.